Design and combinatorial synthesis of a novel kinase-focused library using click chemistry-based fragment assembly

被引:12
作者
Irie, Takayuki [1 ]
Fujii, Ikuo [2 ]
Sawa, Masaaki [1 ]
机构
[1] Carna Biosci Inc, Drug Discovery Res, BMA, Chuo Ku, Kobe, Hyogo 6500047, Japan
[2] Osaka Prefecture Univ, Grad Sch Sci, Dept Biol Sci, Naka Ku, Sakai, Osaka 5998531, Japan
关键词
Kinase inhibitors; Click chemistry; Triazoles; Kinase-privileged fragment; Fragment evolution; RUTHENIUM-CATALYZED CYCLOADDITION; DRUG DISCOVERY; ALKYNES; AZIDES; INHIBITORS; DISEASE;
D O I
10.1016/j.bmcl.2011.10.076
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Fragment-based lead discovery is a new approach for lead generation that has emerged in the past decade. Because the initial fragments identified in the fragment screening typically show weak binding affinity, an intensive medicinal chemistry effort would be required to grow initial fragments into a potential lead compound. Here we demonstrate a kinase focused evolved fragment (KFEF) library, constructed by click chemistry-based fragment assembly, that is a valuable source of kinase inhibitors. This combinatorial assembly of two fragments, kinase-privileged alkyne fragments and diversified azide fragments, by two cycloaddition reactions shows a unique potential for the one-step synthesis of structurally diverse evolved fragments. The screening of this triazole-based KFEF library allowed the rapid identification of potent lead candidates for FLT3 and GSK3 beta kinase. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:591 / 596
页数:6
相关论文
共 21 条
[1]   Ligand efficiency indices as guideposts for drug discovery [J].
Abad-Zapatero, C ;
Metz, JT .
DRUG DISCOVERY TODAY, 2005, 10 (07) :464-469
[2]   The role of protein phosphorylation in human health and disease - Delivered on June 30th 2001 at the FEBS Meeting in Lisbon [J].
Cohen, P .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2001, 268 (19) :5001-5010
[3]   Recent developments in fragment-based drug discovery [J].
Congreve, Miles ;
Chessari, Gianni ;
Tisi, Dominic ;
Woodhead, Andrew J. .
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (13) :3661-3680
[4]   2-aminothiazole as a novel kinase inhibitor template.: Structure-activity relationship studies toward the discovery of N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl)]-2-methyl-4-pyrimidinyl]amino)]-1,3-thiazole-5-carboxamide (Dasatinib, BMS-354825) as a potent pan-Src kinase inhibitor [J].
Das, Jagabandhu ;
Chen, Ping ;
Norris, Derek ;
Padmanabha, Ramesh ;
Lin, James ;
Moquin, Robert V. ;
Shen, Zhongqi ;
Cook, Lynda S. ;
Doweyko, Arthur M. ;
Pitt, Sidney ;
Pang, Suhong ;
Shen, Ding Ren ;
Fang, Qiong ;
de Fex, Henry F. ;
McIntyre, Kim W. ;
Shuster, David J. ;
Gillooly, Kathleen M. ;
Behnia, Kamelia ;
Schieven, Gary L. ;
Wityak, John ;
Barrish, Joel C. .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (23) :6819-6832
[5]   Transforming fragments into candidates: small becomes big in medicinal chemistry [J].
de Kloe, Gerdien E. ;
Bailey, David ;
Leurs, Rob ;
de Esch, Iwan J. P. .
DRUG DISCOVERY TODAY, 2009, 14 (13-14) :630-646
[6]  
Erlanson DA., 2009, KINASE INHIBITOR DRU, P461, DOI [10.1002/9780470524961.ch18, DOI 10.1002/9780470524961.CH18]
[7]   Knowledge based prediction of ligand binding modes and rational inhibitor design for kinase drug discovery [J].
Ghose, Arup K. ;
Herbertz, Torsten ;
Pippin, Douglas A. ;
Salvino, Joseph M. ;
Mallamo, John P. .
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (17) :5149-5171
[8]   Synthesis, crystal structure, and activity of pyrazole-based inhibitors of p38 kinase [J].
Graneto, Matthew J. ;
Kurumbail, Ravi G. ;
Vazquez, Michael L. ;
Shieh, Huey-Sheng ;
Pawlitz, Jennifer L. ;
Williams, Jennifer M. ;
Stallings, William C. ;
Geng, Lifeng ;
Naraian, Ashok S. ;
Koszyk, Francis J. ;
Stealey, Michael A. ;
Xu, Xiangdong D. ;
Weier, Richard M. ;
Hanson, Gunnar J. ;
Mourey, Robert J. ;
Compton, Robert P. ;
Mnich, Stephen J. ;
Anderson, Gary D. ;
Monahan, Joseph B. ;
Devraj, Rajesh .
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (23) :5712-5719
[9]   The GSK3 hypothesis of Alzheimer's disease [J].
Hooper, Claudie ;
Killick, Richard ;
Lovestone, Simon .
JOURNAL OF NEUROCHEMISTRY, 2008, 104 (06) :1433-1439
[10]   Signal transduction therapy with rationally designed kinase inhibitors [J].
Keri, Gyoergy ;
Orfi, Laszlo ;
Eros, Daniel ;
Hegymegi-Barakonyi, Balint ;
Szantai-Kis, Csaba ;
Horvath, Zoltan ;
Waczek, Frigyes ;
Marosfalvi, Jeno ;
Szabadkai, Istvan ;
Pato, Janos ;
Greff, Zoltan ;
Hafenbradl, Doris ;
Daub, Henrik ;
Mueller, Gerhard ;
Klebl, Bert ;
Ullrich, Axel .
CURRENT SIGNAL TRANSDUCTION THERAPY, 2006, 1 (01) :67-95